- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Fluticasone Propionate/Formoterol Fumarate
Total 738 results
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease | Asthma
-
The First Affiliated Hospital of Guangzhou Medical...Guangdong Provincial Hospital of Traditional Chinese Medicine; Tongji Hospital and other collaboratorsNot yet recruiting
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveFrance, Germany, Spain, Russian Federation, Belgium, Ukraine, Philippines, Italy, Poland
-
DeyCompleted
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, Canada, New Zealand
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Sweden, Ukraine, United Kingdom
-
Pearl Therapeutics, Inc.Withdrawn
-
GlaxoSmithKlineCompleted
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
GlaxoSmithKlineCompletedAsthmaGermany, Poland, United States, France, Netherlands, South Africa, United Kingdom, Norway
-
NovartisCompleted
-
Makerere UniversityUniversity of CopenhagenCompletedBacterial Pneumonia | Acute Asthma | Viral PneumoniaUganda
-
ORA, Inc.CompletedAllergic Rhinitis | Allergic ConjunctivitisUnited States
-
Ceragenix PharmaceuticalsCompleted
-
Zhujiang HospitalUnknown
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownPatients With Active Non-segmental Vitiligo. | Evaluation of the Efficacy of UVB and Fluticason Proprionate 0.05% | Cream Compared to NB-UVB Alone in Patients With Non-segmental VitiligoNetherlands
-
MEDA Pharma GmbH & Co. KGCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, Belgium, Brazil, Bulgaria, China, Denmark, France, Germany, Greece, Hungary, Italy, Netherlands, New Zealand, Philippines, Poland, Russian Federation, South Africa, Spain, Taiwan, Tunisia, Turkey, Ukraine, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineWithdrawnPulmonary Disease, Chronic Obstructive
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
AstraZenecaQuintilesIMS, Inc.WithdrawnChronic Obstructive Pulmonary Disease
-
AO GENERIUMCompletedBronchial AsthmaRussian Federation
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseRomania, Czech Republic
-
Ellodi Pharmaceuticals, LPAvailableEosinophilic EsophagitisUnited States
-
Ellodi Pharmaceuticals, LPCompletedEosinophilic EsophagitisAustralia, United States
-
Fraunhofer-Institute of Toxicology and Experimental...Completed
-
AstraZenecaRecruitingChronic Obstructive Pulmonary DiseaseGermany, Spain, United States, China, Korea, Republic of, Argentina, United Kingdom, Canada
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
McGill University Health Centre/Research Institute...Completed
-
NovartisSchering-PloughCompletedHealthyUnited Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAsthmaAustria, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Russian Federation, Spain, Sweden, United Kingdom
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Mylan Pharma UK Ltd.Completed
-
University Hospital, AntwerpAstraZenecaCompletedChronic Obstructive Pulmonary DiseaseBelgium
-
David Andrew WellmanNational Institutes of Health (NIH); American Heart AssociationCompletedHeart FailuresUnited States
-
Saint Francis CareSunovionCompleted
-
Adare Pharmaceuticals, Inc.CompletedEosinophilic EsophagitisSpain, United States, Belgium, Switzerland, Germany, Canada
-
GlaxoSmithKlineCompleted
-
Netherlands Institute for Pigment DisordersWithdrawn